OGN:NYSE
Organon & Co
USD 13,90
0,00%
(0,00) 1D
16 Nov., 11:04:27 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,88
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,53 m
Volume
862,44 k
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,07
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,88
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,53 m
Volume
862,44 k
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,07
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
upi
·
1 uur gelede
KB Kookmin Bank debuts S&P 500-linked dollar deposit product
MarketWatch
·
18 minute gelede
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
Coinpaper
·
1 uur gelede
Stock Market Today: S&P 500 and Nasdaq Fall as Nvidia Selloff Deepens
Traders Union
·
30 minute gelede
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com